What Is Enclomiphene?
Enclomiphene is the active isomer of clomiphene citrate—a selective oestrogen receptor modulator (SERM) that raises your body's own testosterone production without requiring external hormone injection. It does this by blocking oestrogen's negative feedback on your hypothalamus and pituitary gland, signalling your body to produce more LH (luteinising hormone) and FSH (follicle-stimulating hormone), which in turn stimulate testosterone synthesis in the testes.
The key distinction: enclomiphene is half of what's in Clomid. When you take clomiphene citrate, you're actually taking a 50/50 mixture of two isomers—enclomiphene (the active one) and zuclomiphene (the long-lived, problematic one). Zuclomiphene accumulates in your system over weeks, causing side effects like blurred vision and mood disturbances. Enclomiphene alone avoids this entirely.
For men over 35 considering testosterone optimisation, enclomiphene sits in an interesting middle ground: it's not TRT (which suppresses your own production and fertility), yet it delivers measurable testosterone elevation. It's prescription-only in the UK, exists in a grey legal area online, and the clinical evidence—while solid—remains limited compared to TRT.
How Enclomiphene Works
Your testosterone production operates via a classical feedback loop. Your hypothalamus releases GnRH (gonadotropin-releasing hormone), which signals your pituitary to release LH and FSH. These hormones stimulate the Leydig cells in your testes to produce testosterone. When testosterone rises, it (along with converted oestrogen) signals the hypothalamus and pituitary to reduce GnRH, LH, and FSH—a negative feedback brake.
Enclomiphene blocks oestrogen receptors in your hypothalamus. With oestrogen unable to signal "we have enough testosterone," your hypothalamus keeps firing GnRH, your pituitary keeps releasing LH and FSH, and your testes keep producing testosterone.
This mechanism has a significant advantage over TRT: it preserves your body's own production and sperm output. When you inject testosterone, your LH and FSH crash (because your body senses plenty of testosterone and no longer needs to make its own). Your testes shrink, and sperm production plummets. Stop TRT, and it takes months to recover. Enclomiphene, by contrast, drives LH and FSH higher, maintaining testicular function and fertility.
The effect isn't subtle. Clinical studies show testosterone rises of 300–600 ng/dL from baseline in men with low-normal or mildly suppressed testosterone.
Enclomiphene vs Clomiphene vs TRT
Clomiphene citrate (Clomid): The standard SERMs used in the UK. You're getting 50% enclomiphene and 50% zuclomiphene. Zuclomiphene is long-lived (half-life ~30 hours) and accumulates, causing:
- Blurred or foggy vision (in 10–15% of users, sometimes persistent)
- Mood swings, anxiety, or low mood
- Joint aches
- Slower response onset (takes 4–6 weeks to steady-state)
Zuclomiphene lingers for months after you stop. Many men tolerate clomiphene fine; others find the side effects intolerable.
Enclomiphene alone: Shorter half-life (~2.5 hours), no zuclomiphene accumulation. Side effects are milder and reversible. Response is faster (days to weeks). The tradeoff: less clinical data, availability primarily through research use or grey-market suppliers.
TRT (testosterone replacement therapy): Exogenous testosterone. Suppresses your own LH/FSH within days, causing testicular atrophy, infertility, and dependence. Once started, discontinuation requires months of recovery (or adjunct therapies like hCG to restart production). TRT does reliably raise testosterone to therapeutic levels and has decades of safety data. It's appropriate for hypogonadal men, but it's not a reversible "optimisation" tool.
| Factor | Clomiphene | Enclomiphene | TRT | |--------|-----------|--------------|-----| | Preserves fertility | Yes | Yes | No | | Raises your own T | Yes | Yes | No | | Reversible | Yes (takes months) | Yes (weeks) | No (months+) | | Side effects | Vision, mood, joint pain | Milder, shorter duration | Suppression, atrophy, dependence | | Clinical data | Extensive | Growing | Extensive | | UK availability | Prescription | Prescription/grey market | Prescription |
Clinical Evidence
The strongest data comes from a handful of trials:
Kim et al. (2013), Journal of Clinical Endocrinology & Metabolism: 59 men with low or low-normal testosterone (300–500 ng/dL). Enclomiphene 12.5–25mg daily for 12 weeks. Results: testosterone rose to a mean of ~650 ng/dL, LH and FSH elevated, sperm count maintained or improved, no serious adverse events. Vision or mood disturbances were absent. This is the proof-of-concept trial.
Wiehle et al. (2014), Journal of Urology: Larger trial, 154 men, enclomiphene vs placebo, 12 weeks. Testosterone rose ~400 ng/dL above baseline in the enclomiphene group. LH/FSH elevated. Again, vision disturbances notably absent.
Longer-term data: Fewer trials exist beyond 12–16 weeks. Most data suggests tolerance (your body adjusts), requiring dose escalation or periodic breaks. No long-term studies exist in healthy young men using enclomiphene purely for "optimisation"—the existing data is in men with hypogonadism.
The takeaway: enclomiphene works to raise testosterone and preserve fertility. The evidence base is smaller than TRT, but it's solid enough for clinical use. Off-label or grey-market use sits outside this data, and your mileage may vary.
Who Enclomiphene Suits
You're a good candidate if:
- Your baseline testosterone is low-normal (400–550 ng/dL) or mildly suppressed, and you want to optimise without TRT.
- You value fertility preservation highly.
- You want a reversible intervention (you can stop and recover within weeks).
- You're willing to engage with a private doctor or accept grey-market sourcing and its legal ambiguity.
- You're over 35 and not in elite sport (where it may be banned).
You're not a good candidate if:
- Your testosterone is frankly low (below 300 ng/dL); you'd likely need TRT for symptom relief.
- You want simplicity and have no fertility concerns (TRT is more straightforward).
- You're under 25; your natural production is likely fine.
- You can't tolerate any uncertainty (enclomiphene's UK status is murky).
Getting Enclomiphene in the UK
The legal situation: Enclomiphene is prescription-only in the UK. No licensed product exists under that name—it's not marketed as such by pharmaceutical manufacturers. You have three routes:
1. Private doctor prescription: A small number of UK private clinics (often telemedicine-based, specialising in male health) will prescribe enclomiphene off-label if you present with low testosterone and fertility concerns. Cost: £150–400 per consultation, then sourcing the compound through a pharmacy (costs vary; expect £100–300 monthly). Legality: fully lawful; doctor-supervised; tracked records.
2. Clomiphene citrate (Clomid/Serophene): Legally prescribed via NHS or private for male hypogonadism (though NHS is restrictive). You're getting 50% enclomiphene and 50% zuclomiphene, with the vision/mood side effects. Cheaper than pure enclomiphene; legal and documented. Many men tolerate it well.
3. Grey-market sourcing: Enclomiphene is available through online pharmaceutical suppliers operating in grey zones (some legitimate compounding pharmacies, some less so). Legality: murky. You're not breaking the law by receiving a prescription compound; you may be skirting regulations by sourcing without a valid prescription. Quality control varies wildly. We won't link to suppliers here; if you pursue this route, research thoroughly and accept the risk.
Realistic expectation: Most UK men interested in enclomiphene either use clomiphene citrate (legal, simpler, more side effects) or source enclomiphene privately with doctor oversight. DIY sourcing is common but carries unknowns.
Dosing and Protocol
Standard enclomiphene dosing from trials:
- 12.5–25mg daily, in a single morning dose
- Duration: 12–16 weeks initially, then evaluate
- Blood work: baseline testosterone, LH, FSH; repeat at 6 weeks and 12 weeks
Typical response: testosterone rises within 2–4 weeks. Platelet usually stabilises by week 8–12. Some men report mood or energy improvements within the first two weeks.
Common protocol from private practitioners: Start 12.5mg daily for 4 weeks, assess bloodwork, then increase to 25mg if needed. Many men find 12.5mg adequate for maintenance.
Cycling: Longer-term users often cycle (e.g., 12 weeks on, 4 weeks off) to avoid tolerance, though data on optimal protocols is limited.
Side Effects and Contraindications
Enclomiphene is generally well-tolerated. Reported side effects:
- Mild headache (10–20% of users, usually resolves within days)
- Nausea (rare, typically transient)
- Mood stability (some users report slight irritability, uncommon)
- Acne (possible if testosterone rises significantly)
- Vision issues (rare with pure enclomiphene; common with clomiphene due to zuclomiphene)
Contraindications:
- Active prostate cancer or suspected prostate cancer
- Undiagnosed liver disease
- Severe cardiovascular disease
- Pituitary or testicular tumours
Monitoring: If you use enclomiphene (privately or grey-market), regular bloodwork is essential. Testosterone, LH, FSH, oestradiol, liver function, and PSA (if over 40) should be monitored. Unmonitored use carries unknown risks.
Tolerance and Long-Term Use
One limitation: your body adapts. Enclomiphene elevates testosterone acutely, but over weeks or months, your hypothalamus may become desensitised to the oestrogen blockade, and testosterone gains plateau or diminish. This is why some protocols include cycling or periodic breaks.
Long-term data (2+ years) is scarce. The clinical trials were 12–16 weeks. No robust studies track men on enclomiphene for years. Men using it long-term anecdotally report sustained benefits, but this isn't evidence-grade.
The Honest Bottom Line
Enclomiphene is a legitimate tool for men over 35 seeking testosterone optimisation while preserving fertility. The mechanism is solid, the short-term clinical evidence is credible, and the side-effect profile is favourable compared to clomiphene or TRT.
But it exists in a legal grey zone in the UK. You'll either need a private doctor (expensive, reliable) or grey-market sourcing (cheaper, riskier). If you pursue it, ensure bloodwork monitoring; don't fly blind.
For most men with low-normal testosterone and no fertility concerns, clomiphene citrate (standard Clomid) is the legal, cheaper starting point—you just tolerate zuclomiphene's baggage. For men who value fertility preservation and can navigate UK private healthcare, enclomiphene is worth exploring with a doctor.
TRT, for comparison, is simpler and has stronger evidence—but it's a one-way ticket to dependence and infertility (temporarily). Enclomiphene lets you optimise and exit. Choose based on your priorities: simplicity and cost (TRT), fertility and reversibility (enclomiphene), or the legal middle ground (clomiphene).